Effects of castration and testosterone administration on angiotensin II receptor mRNA expression and

Ryuto Nakazawa1, Masami Tanaka, Takeshi Takahashi

  • 1Department of Urology, St. Marianna University, Kawasaki, Japan.

Endocrine Journal
|January 24, 2007
PubMed

Insights

Castration increases angiotensin II receptor type 2 (AT2 receptor) mRNA and caspase-3 in rat bladders, effects reversed by testosterone. Bladder AT2 receptor and apoptosis are androgen-dependent.

Area of Science:

  • Urology
  • Endocrinology
  • Molecular Biology

Background:

  • Androgen levels significantly influence various physiological processes.
  • The role of androgens in regulating urinary bladder function and molecular pathways remains incompletely understood.
  • Angiotensin II receptors and apoptosis-related proteins are implicated in bladder pathophysiology.

Purpose of the Study:

  • To investigate the impact of castration and subsequent androgen (testosterone) administration on angiotensin II receptor (AT1 and AT2) mRNA expression in rat bladders.
  • To examine the effects of altered androgen levels on the expression of key apoptosis-related proteins (caspase-3, Bcl-2, Bax, MAP kinase phosphatase-1) in the rat urinary bladder.
  • To elucidate the relationship between androgen status and AT2 receptor expression and apoptosis in the urinary bladder.

Main Methods:

  • Utilized a rat model with three groups: control (sham operation), castration, and castration plus testosterone administration.
  • Quantified mRNA expression of angiotensin converting enzyme (ACE), AT1 receptor, and AT2 receptor using real-time PCR.
  • Determined the protein expression levels of apoptosis-related factors (caspase-3, Bcl-2, Bax, MAP kinase phosphatase-1) via Western blotting.

Main Results:

  • Castration led to a significant increase in AT2 receptor mRNA and caspase-3 protein expression in rat bladders.
  • Testosterone administration reversed these increases, returning AT2 receptor and caspase-3 levels to control levels.
  • Bcl-2 and Bax protein expression remained unchanged, while MAP kinase phosphatase-1 expression increased post-castration but was reduced with testosterone treatment.

Conclusions:

  • Urinary bladder expression of AT2 receptor mRNA and caspase-3 protein is significantly influenced by the androgen environment and is androgen-dependent.
  • Changes in androgen levels affect the expression of specific apoptosis-related proteins in the rat urinary bladder.
  • This study provides the first evidence clarifying the direct relationship between AT2 receptor and androgen regulation within the urinary bladder.

Related Concept Videos

Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...